baber/WOPTO huggingface dataset:
Patent TR-200100737-T2 (TR)
Title: Osteoprotegerin ligand aktivitesini düzenleme yöntemi
Inventor: HALKIER TORBEN
IPC: C12N15/09
Filed: 1999-09-13
Abstract: Bulus osteoprotegerin ligandinin (OPGL, TRANCE) biyolojik aktivitesini düzenleyen dolayisiyla osteoporoz gibi özelligi asiri kemik kütlesi kaybi olan hastaliklarin tedavi edilmesini/iyilestirmesini mümkün kilan yeni bir yöntem saglamaktadir. Düzenleme ihtiyaci olan bir bireyde OPGL'ye karsi bir bagisiklik tepkisinin olusturulmasiyla gerçeklestirilir. Bagisiklik tepkileri OPGL'nin imünojenik varyantlariyla klasik asilamayla veya OPGL varyantini kodlayan nükleik asitlerin nükleik asit asilamasiyla arttirilabilir. Bulus ayrica, bulusta yararli olan bilesimlerle, polipeptidlerle ve nükleik asitlerle ve ayni zamanda bunlarin hazirlanmasinda yararli olan vektörler ve dönüstürülmüs alici hücrelerle ilgilidir.
Patent DE-602004000311-T2 (DE)
Inventor: UEDA TAKASHI
IPC: B62J11/00
Filed: 2004-08-20
Granted: 2006-08-10
Abstract: A measurement apparatus includes a speed sensor (12), a cadence sensor (10) and a display portion (16). The apparatus further includes a transmit portion (14) for wirelessly transmitting signals detected by the speed sensor (12) and the cadence sensor (10) to the display portion (16). The transmit portion (14) is provided with a shaft portion extending in one direction, which rotatably supports the cadence sensor (10) and the speed sensor (12). A measurement body portion (15) including the speed sensor (12), the cadence sensor (10) and the transmit portion (14) is mounted on chain stay (5). The display portion (16) is mounted on a portion of a handle (3) in the field of vision of a rider of the bicycle, and it has functions of receiving and processing signals transmitted from the transmit portion (14), and displaying prescribed information. Thus, the measurement apparatus that can easily be mounted to a bicycle and the sensor apparatus applied thereto are obtained. <IMAGE>
Patent DE-602004003447-T2 (DE)
Inventor: LE CREFF MICHEL
IPC: G06F1/18
Filed: 2004-09-29
Granted: 2007-09-27
Abstract: The card has a control module for controlling a coupling module and connected logically to main and auxiliary supply modules. The control module controls the coupling module to electrically decouple an internal bus (PCI2) from an internal bus (PCI1) to permit the card to operate independent of a micro-computer (UE) when the card is supplied by the auxiliary module and the computer is not supplied by the main module.
Patent DE-602004007364-T2 (DE)
Inventor: COLPAERT FRANCIS
IPC: A61P25/00
Filed: 2004-03-15
Granted: 2008-03-06
Abstract: The use of 1-benzoyl-4-(((pyridin-2-ylmethyl)-amino)-methyl)-piperidine derivatives (I) for treating the symptoms of chronic pain of neuropathic or psychogenic origin is new. The use of pyridine derivatives of formula (I), or their mineral or organic acid addition salts, is claimed in the production of medicaments for treating the symptoms of chronic pain of neuropathic or psychogenic origin. [Image] U : H; or may also be Me if V = W = H; V : H or Cl; or may also be Me if U = W = H; W : H or F; or may also be Me if U = V = H; X : H or F; Y : Cl or Me; Z : H, F, Cl or Me; A : H, F, Cl, 1-5C alkyl, fluoroalkyl (e.g. CH 2F, CHF 2, CF 3, CHFMe or CF 2Me), 3-5C cycloalkyl, optionally substituted 5-membered aromatic heterocyclyl containing 1-4 of N, O and/or S as heteroatom(s) (provided that not more than one O and/or S is present), OR 1, SR 1, NR 2R 3, azetidino, pyrrolidino or alkoxycarbonyl (preferably COOMe or COOEt); R 11-5C alkyl, CH 2F, CF 3 or 3-5C cycloalkyl; R 2, R 3H, 1-5C alkyl, CF 3 or cyclopropyl. ACTIVITY : Analgesic. In tests for activity against central neuropathic pain induced by spinal column lesions in rats (see Pain, 1996, 66, 279-286), (3-chloro-4-fluorophenyl)-(4-fluoro-(((5-methyl-pyridin-2-ylmethyl)-amino)-methyl)-piperidin-1-yl)-methanone (Ia) was administered (as the fumarate) at a constant rate of 0.63 mg per day for 14 days using an implanted analgesic pump. Statistically significant analgesia was observed from day 10 of the treatment (demonstrating symptomatic analgesic action); and the analgesia remained at the same level from day 15 after cessation of the treatment for a further 14 days (demonstrating curative analgesic action). MECHANISM OF ACTION : 5-HT-1A receptor agonist.
Patent DE-602004012698-T2 (DE)
Inventor: CASTRO PASCAL
IPC: F01P11/14
Filed: 2004-12-03
Granted: 2009-04-16
Abstract: The device has a memory in which abnormality conditions are stored, a pressure sensor (200), and a gas bubble detection sensor (300), where each condition has a specific combination of measurement results of pressure, temperature and rate of bubbles. A signal processing unit (400) compares the sensors` measurements with pre-recorded abnormality conditions to identify an appearance of a condition in a cooling system (50). An independent claim is also included for a process for monitoring a cooling system of a heat engine of a motor vehicle.
Patent DE-602004012845-T2 (DE)
Inventor: NORDIN BJOERN
IPC: G06K9/00
Filed: 2004-02-12
Granted: 2009-04-09
Abstract: A method for creating a representation of a finger- print is disclosed. The method comprises creating unique pairs of minutiae points identified in the fingerprint, each pair of minutiae points being represented by a distance between the minutiae points and by angles associated with the respective minutiae points included in the pair. Moreover, methods are disclosed for use in checking a person's identity and in creating reference data for checking a person's identify. Moreover, computer program products and devices for carrying out the methods are disclosed.
Patent DE-602005002747-T2 (DE)
Inventor: BROWN MICHAEL K
IPC: G06F12/14
Filed: 2005-08-11
Granted: 2008-02-07
Abstract: Increasing security for a hand-held data processing device with communication functionality where such a device includes an access-ordered memory cache relating to communications carried out by the device. The hand-held data processing device has a locked state that is entered by the device receiving or initiating a trigger. On occurrence of the trigger to enter the locked state the memory cache is reordered so as to disrupt the access-ordering of the cache to obscure device traffic information and thus increase the security of the device in the locked state.
Patent DE-69019710-T3 (DE)
Inventor: EASTHAM DAVID
IPC: F16C33/12
Filed: 1990-06-18
Granted: 2001-02-01
Abstract: PCT No. PCT/EP90/00970 Sec. 371 Date Jan. 30, 1991 Sec. 102(e) Date Jan. 30, 1991 PCT Filed Jun. 18, 1990 PCT Pub. No. WO91/00375 PCT Pub. Date Jan. 10, 1991.Bearings having an overlay (14) deposited by cathodic sputtering. In one example the overlay comprises an aluminum matrix (22) containing a dispersed phase (24) of tin. The overlay may contain a relatively low content of tin adjacent the interface (18) with the substrate (10;12) rising to a relatively high content at the surface. The surface may comprise a layer (26) of substantially pure tin to act as a sacrificial overlay during initial running of the bearing.
Patent DE-69403072-T3 (DE)
Inventor: HEIJL ANDERS
IPC: A61B3/024
Filed: 1994-03-22
Granted: 2001-07-19
Abstract: In a method of testing a subject's perception of successively presented visual stimuli, a predetermined preliminary response time window is used at the beginning of the test to preliminarily classify the visual stimuli as "seen" or "not seen" depending on whether or not a response is received from the subject within the preliminary response time window. To permit reclassification of the visual stimuli at a later stage, the time of reception of every response, whether outside or within the preliminary response time windows, is stored. When an appropriate number of stimuli have been presented, a subject-adapted response time window is determined on the basis of the stored times of reception of the responses. This subject-adapted response time window is used for reclassifying the preliminarily classified stimuli. Moreover, the frequency of false positive responses can be determined on the basis of the number of responses received outside the preliminary response time window and/or the subject-adapted response time window. An apparatus for carrying out the testing includes a control unit operating according to the method.
Patent DK-1142167-T3 (DK)
Inventor: GEORGES THIERRY
IPC: H04B10/2525
Filed: 2000-01-11
Granted: 2003-03-17
Abstract: The invention concerns a long distance optical transmission system comprising transmitting means (1) and pulse receiving means (2) and an optical line (3) extending between said transmission and reception means and comprising alternating sections (3a, 3b) of sign dispersion fibres with opposite chromatic dispersion, and a plurality of amplifiers (4). The invention is characterised in that the optical line includes several pairs of sign dispersion fibre sections with opposite chromatic dispersion between two amplifiers, and the cumulated dispersion C of the majority of the sections of the optical line verifies the relationship |C|  DELTA  nu <2><0.3 wherein C is expressed in ps/nm and wherein  DELTA  nu  is the spectral value at mid-height of the pulses expressed in THz.
Patent DK-1161297-T3 (DK)
Inventor: BIRKE PETER
IPC: B01J23/755
Filed: 2000-03-01
Granted: 2004-02-09
Abstract: A hydrogenation catalyst and a process for its production, wherein the catalyst can be used for the hydrogenation of nitro groups in nitroaromatics to form the corresponding amines in the presence of water.
Patent DK-1183847-T3 (DK)
Inventor: REIF HOLGER
IPC: H04L29/06
Filed: 2000-05-15
Granted: 2004-08-09
Abstract: The invention relates to a method for the secure transmission of protected data from a first terminal (1) within a first security area (6) to a second terminal (2) within a second security area (10), which is different from the first security area. The inventive method comprises the following steps: providing useful data in the first terminal; generating the protected data in the first terminal by adding first security characteristics (8a) to the useful data; transmitting the protected data within the first security area to an area transformer (9), by a first communications connection (4), said area transformer being integrated into both the first and the second security areas; transforming at least some of the first security characteristics into second security characteristics (11a) by means of the area transformer; transmitting the protected data within the second security area to a second terminal, by a second communications connection (7). The protected data can then be converted back into useful data in said second terminal.
Patent DK-1302148-T3 (DK)
Inventor: BYUNG-SUN YANG
IPC: A47L5/36
Filed: 2002-05-23
Granted: 2006-08-21
Abstract: The present invention relates to a dust collection unit for use in a vacuum cleaner. According to the present invention, there is provided a dust collection unit for use in a vacuum cleaner which comprises a cylindrical casing 130 in which air introduced through an inlet port is formed into spiral flow and of which an upper end is open; a cover 110 for opening and closing the upper end of the casing; a filter 114 which is installed on a bottom surface of the cover and formed in the shape of a cylinder having a predetermined length and by which fine foreign substances can be filtered out when the air is introduced from the exterior thereof, and through which the air is discharged downwardly; and an exhaust duct 138 which comes into close contact with a bottom surface of the filter and including an exhaust port 136 on a side surface of the casing to discharge the air from the filter to the exterior of the casing. It is preferred that the exhaust port of the casing be formed at a lower portion of the side surface of the casing. <IMAGE>
Patent DK-1262186-T3 (DK)
Inventor: BOETTNER WAYNE A
IPC: A61P31/04
Filed: 2002-05-30
Granted: 2004-07-26
Abstract: Aqueous antibiotic compositions comprising a mixture of an azalide compound, propylene glycol, and one or more acids, and methods for preparing such compositions, are disclosed. <IMAGE>
Patent DK-1386084-T3 (DK)
Inventor: MIIKKULAINEN TATU
IPC: F15B13/04
Filed: 2002-04-11
Granted: 2006-05-22
Abstract: The aim of the invention is to improve a hydraulic control assembly comprising a directional control valve that can be proportionally adjusted, in such a way that even for a single-action hydraulic cylinder a significant increase in the lowering speed of the hydraulic consumer is prevented as the load pressure accumulates, in a simple manner. To achieve this, a measuring piston (82) can be subjected to a pressure prevailing in a first consumer chamber (38) during a displacement of a control piston (32) in the second direction. During the lowering operation, the load pressure prevailing in the first consumer chamber thus impinges on the measuring piston. The compensatory force thus created increases with the accumulating load pressure and displaces the control piston to reduce the flow rate cross-section between the first consumer chamber and the outlet chamber (44). A pressure differential, which increases by means of an accumulating load pressure can therefore be partially or wholly compensated, or even overcompensated by the reduction of the flow rate cross-section, thus limiting the lowering speed.
Patent DK-1442076-T3 (DK)
Inventor: FULFORD ROLAND
IPC: C08J3/00
Filed: 2002-08-08
Granted: 2007-02-05
Abstract: The invention relates to a process for converting an elastomer from scrap to a regenerated elastomer which comprises the steps of: (a) introducing the elastomer from scrap into a vessel; (b) agitating the elastomer from scrap; (c) heating the elastomer from scrap to a temperature below a temperature where the elastomer begins to degrade; (d) introducing an oil into the vessel and admixing together the elastomer from scrap and the oil; and (e) cooling down the so formed regenerated elastomer, whereby the regenerated elastomer has properties similar to a corresponding virgin elastomer. Steps (b) and (c) are carried out simultaneously or separatelty and steps (c) and (d) are carried out simultaneously or separately. A regenerated elastomer and its use are also disclosed.
Patent DK-1432872-T3 (DK)
Inventor: NILSSON NILS-AKE
IPC: C08L95/00
Filed: 2002-10-07
Granted: 2009-08-17
Abstract: A road surfacing for reducing rolling noise includes particles bonded together so as to form between them air-permeable channels. The material of the road surfacing includes a ballast material comprising granules of stone and rubber and a bitumen binder adhering to the granules of stone and rubber. The granules of stone have particle sizes ranging from 0.5 to 24 mm and the granules of rubber have particle sizes ranging from 0.5 to 8 mm. A method of manufacturing the material as well as a method of laying a road surfacing are also described.
Patent DK-1455959-T3 (DK)
Inventor: TEICHGRABER VOLKER
IPC: B07C3/00
Filed: 2002-10-14
Granted: 2006-02-13
Abstract: The invention relates to a method and device for processing mail wherein information located on at least one surface of the mail is detected. Address information determined by means of the information located on the surface of the mail is compared with available address information in a data bank or in a database drawn up therefrom. In querying the data bank or database, the address information thus determined is associated with new address information and the address information established by querying the data bank or database is applied to the mail as new address information.
Patent DK-1404852-T3 (DK)
Inventor: HOWLEY PAUL
IPC: C12N15/86
Filed: 2003-05-14
Granted: 2006-05-08
Abstract: The invention concerns recombinant Modified vaccinia virus Ankara comprising in the viral genome an expression cassette comprising the cowpox ATI promoter or a derivative thereof and a coding sequence, wherein the expression of the coding sequence is regulated by said promoter. The virus may be useful as a vaccine or as part of a pharmaceutical composition.
Patent DK-1515758-T3 (DK)
Inventor: LERF RETO
IPC: A61F2/00
Filed: 2003-05-27
Granted: 2009-07-06
Abstract: The invention relates to a method of producing an open-pored coated joint replacement implant, wherein at least one layer of a biocompatible metal or an alloy thereof is applied to a virgin surface of the implant, to produce an implant surface. A surface micro-structure is then produced on the implant surface. That is carried out by means of etching of the implant surface, for example by means of an acid bath or by means of plasma etching, or by the application of fine biocompatible particles to the implant surface. The layer thickness of the open-pored surface layer is in the range from 0.5 mm to 1.5 mm, the porosity being at least 40%.
Patent DK-1664656-T3 (DK)
Inventor: BERGGREN GOETE GUNNAR
IPC: F28F1/22
Filed: 2003-09-19
Granted: 2008-04-14
Abstract: A heat exchanger cooling fin ( 401 ), for use in a fluid flow environment, comprising a fin plate ( 402 ) having a series of substantially mutually parallel louvres ( 403 ), each louvre ( 403 ) having a convex curved surface ( 404 ) facing in the opposite direction to each adjacent louvre ( 403 ), said series of louvres defining a nominal fluid flow path along the series over said convex curved surface ( 404 ) of each louvre ( 403 ).
Patent DK-1616877-T3 (DK)
Inventor: WAGNER STEFAN
IPC: A61K38/16
Filed: 2004-07-15
Granted: 2008-09-22
Abstract: The present invention relates to reagents for diagnosis and/or therapy of latex allergy or fruit allergy and to a method for the preparation of the reagents.
Patent DK-1521278-T3 (DK)
Inventor: PETERSON ROBERT H
IPC: A61B17/00
Filed: 2003-08-15
Granted: 2007-04-16
Abstract: A footswitch is provided with a base (12), a treadle (14) mounted to the base; and a heel cup (16) slidable retained on the treadle so as to adjustably increase or decrease a length of the treadle so as to make the footswitch ergonomically more correct for a variety of users. <IMAGE>
Patent DK-1604589-T3 (DK)
Inventor: SCHERRER KURT
IPC: A47B9/04
Filed: 2004-06-11
Granted: 2008-10-20
Abstract: The tabletop (2) is provided with semicircular recesses for the insertion of the upper ends of the legs (3.1, 3.2, 3.3, 3.4) and surrounded by a hollow profile (4.1, 4.2, 4.3, 4.4). Each of the legs (3.1, 3.2, 3.3, 3.4) is equipped with a spindle (7.1, 7.2, 7.3, 7.4) accommodated inside and a hexagonal opening (8.1, 8.2, 8.3, 8.4) at the top. The spindles (7.1, 7.2, 7.3, 7.4) are interconnected with an endless serrated belt (9.1, 9.2, 9.3, 9.4). When one of the legs (3.1, 3.2, 3.3, 3.4) is turned all spindles (7.1, 7.2, 7.3, 7.4) are simultaneously rotated in order to lift or lower the tabletop (2).
Patent DK-1660513-T3 (DK)
Inventor: PAYNE GILLIAN
IPC: C12N5/06
Filed: 2004-07-21
Granted: 2011-05-16
Abstract: Cytotoxic conjugates comprising a cell binding agent and a cytotoxic agent, therapeutic compositions comprising the conjugate, methods for using the conjugates in the inhibition of cell growth and the treatment of disease, and a kit comprising the cytotoxic conjugate are disclosed are all embodiments of the invention. In particular, the cell binding agent is a monoclonal antibody, and epitope-binding fragments thereof, that recognizes and binds the CA6 glycotope. The present invention is also directed to humanized or resurfaced versions of DS6, an anti-CA6 murine monoclonal antibody, and epitope-binding fragments thereof.
Patent DK-1699915-T3 (DK)
Inventor: BADER AUGUSTINUS
IPC: A61K35/407
Filed: 2004-12-30
Granted: 2010-09-13
Abstract: Use of hematopoietic growth factors (I), especially erythropoietin (EPO), thrombopoietin (TPO) or their derivatives, analogs and fragments, to prepare a composition for structural regeneration of tissue, is new. Independent claims are also included for the following: (1) similar use of an EPO-inducing factor (II); (2) carrier structure containing at least one (I) or (II); (3) preparing the structure of (2); and (4) composition comprising cells (A) that have been pretreated, in vitro, with (I). ACTIVITY : Hepatotropic; Osteopathic; Cardiant; Ophthalmological; Uropathic; Antiinflammatory; Antiulcer; Vulnerary; Neuroprotective. Part of the liver was removed from pigs, then the animals (a) given no treatment; (b) treated locally with 10 4> units EPO and a fibrin glue; or (c) treated systemically with 10 4> units EPO on days 0, 3, 7 and 11. After 14 days, the mean liver volume (ml) was (a) 892; (b) 894 and (c) 1073, and liver weight (g) was (a) 1001; (b) 1027 and (c) 1249; where these results for (c) are statistically significant at p less than 0.05. MECHANISM OF ACTION : Promoting regrowth of tissue.
Patent DK-1657535-T3 (DK)
Inventor: KUNDE CHRISTOPH
IPC: G01G19/00
Filed: 2005-11-08
Granted: 2010-07-05
Abstract: The method involves connecting a calibrated cradle unit with a processing device, and detecting the connection of the cradle unit with the device. A calibration of the cradle unit is carried out for placing a franking machine using a calibration factor that is assigned to the machine. The factor is transmitted from a data center to the machine. Selection of the factor is carried out using an input of a user of the machine. An independent claim is also included for a franking arrangement with a franking machine.
Patent DK-1706852-T3 (DK)
Inventor: DOUGLAS RAYMOND
IPC: G08B21/02
Filed: 2005-01-10
Granted: 2008-11-24
Abstract: An identification card (1) having means for generating and transmitting signals into the body of a card holder and means for receiving and interpreting the signals from the card holder's body. The signals are attenuated by bioelectrical impedance of the card holder's body such that the interpretation of the attenuated signals by the interpretation means provides a bioelectrical impedance signature for uniquely identifying the card holder.
Patent DK-1720441-T3 (DK)
Inventor: JANIN PATRICK
IPC: A61B1/317
Filed: 2005-03-03
Granted: 2009-06-29
Abstract: The system has a connector (17) including communication channels (19, 21) for communicating with connecting channels (13, 15) respectively. The channels (19, 21) are disposed with respect to a pressure detector that detects the pressure in the channels (19, 21). The connector is mounted on a mount (11) for communicating irrigation channel (5) and suction channel (9) with the channels (13, 15).
Patent DK-1745144-T3 (DK)
Inventor: BOHLEN HERIBERT
IPC: C12Q1/02
Filed: 2005-05-11
Granted: 2011-02-07
Abstract: Provided are assay systems for determining the therapeutic or toxic effect of a putative drug based on assaying its activity in cells which have been differentiated in vitro from stem cells, and induced to display a phenotype that resembles a disease to be treated.
Patent DK-1773722-T3 (DK)
Inventor: KOOS PAUL
IPC: C02F1/00
Filed: 2005-07-01
Granted: 2012-02-13
Abstract: The present invention relates to a purification device for the purification of a liquid such as water, preferably drinking water, which purification device comprises at least one casing (1) having at least one insert (10), said casing (1) having at least one inlet (8) and at least one outlet (9) for the liquid and said insert (10) comprising at least one filter (15) located in a flow path of the liquid. The purification device comprises at least one galvanic couple (12, 14) located in said flow path. The present invention also relates to an insert and a method of purifying a liquid.